KBLB
Kraig Biocraft Laboratories, Inc.
Price Chart
Latest Quote
$0.10
+0.00 (+0.00%)
Current Price
| Previous Close | $0.10 |
| Open | $0.10 |
| Day High | $0.10 |
| Day Low | $0.10 |
| Volume | 325,694 |
Stock Information
| Shares Outstanding | 1.11B |
| Total Debt | $1.65M |
| Cash Equivalents | $2.89M |
| Net Income | $-3.97M |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Market Cap | $111.30M |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $119.26M |
| Income | $-3.97M |
| Book/sh | $-0.01 |
| Cash/sh | $0.00 |
| Employees | 37 |
Financial Ratios
| Quick Ratio | 0.27 |
| Current Ratio | 0.28 |
Returns & Margins
| ROA | -89.81% |
Ownership
| Insider Ownership | 18.63% |
| Institutional Ownership | 0.01% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | -9.09 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.11 |
| SMA50 | $0.13 |
| SMA200 | $0.11 |
| RSI | 33.33 |
| ATR | 0.0086 |
| Shares Float | 850.74M |
| Volatility | 1.50 |
| Rel Volume | 0.72 |
Performance History
| Week | -9.09% |
| Month | -23.08% |
| Quarter | -16.67% |
| 6 Months | +25.00% |
| YTD | +11.11% |
| Year | +25.00% |
| 3 Years | +150.00% |
| 5 Years | -9.09% |
| 10 Years | +400.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $0.10 | 775,600 |
| 2026-06-24 | $0.10 | 801,700 |
| 2026-06-23 | $0.11 | 1,135,900 |
| 2026-06-22 | $0.10 | 1,154,700 |
| 2026-06-18 | $0.11 | 693,300 |
| 2026-06-17 | $0.11 | 1,014,000 |
| 2026-06-16 | $0.11 | 832,300 |
| 2026-06-15 | $0.11 | 811,600 |
| 2026-06-12 | $0.11 | 1,823,600 |
| 2026-06-11 | $0.12 | 1,680,300 |
| 2026-06-10 | $0.11 | 1,217,100 |
| 2026-06-09 | $0.11 | 726,100 |
| 2026-06-08 | $0.12 | 749,700 |
| 2026-06-05 | $0.12 | 393,700 |
| 2026-06-04 | $0.12 | 710,000 |
| 2026-06-03 | $0.12 | 1,116,000 |
| 2026-06-02 | $0.13 | 1,511,100 |
| 2026-06-01 | $0.12 | 1,580,500 |
| 2026-05-29 | $0.12 | 1,640,600 |
| 2026-05-28 | $0.12 | 1,195,800 |
| 2026-05-27 | $0.12 | 871,500 |
| 2026-05-26 | $0.13 | 1,140,800 |
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. The company's primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and other applications; and military and police for its ballistic protection. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
đ° Latest News
Kraig Biocraft Laboratories Sets Recombinant Spider Silk Production Record with Nearly 2.5 Metric Ton Harvest (KBLB)
InvestorsHub âĸ 2026-06-09T14:49:20Z
Immortalized Silk Gland Cell Line Breakthrough Expands Kraig Biocraftâs Biotech Ambitions (KBLB)
InvestorsHub âĸ 2026-05-18T15:12:33Z
Kraig Biocraft (KBLB) Spider Silk Production Milestone Signals Progress Toward Commercialization
InvestorsHub âĸ 2026-04-30T14:54:26Z
Kraig Biocraft (USOTC:KBLB) Hits 50% Production Milestone â Spider Silk Push Moves Closer to Commercial Scale
InvestorsHub âĸ 2026-04-28T13:51:39Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $529,603 | $484,658 | $609,129 | $660,419 |
| Total Expenses | $3,074,561 | $2,614,794 | $2,121,343 | $2,759,562 |
| Other Income Expense | $133,829 | $-39,887 | $38 | $77,096 |
| Net Non Operating Interest Income Expense | $-458,207 | $-375,099 | $-1,720,709 | $-5,363,337 |
| Interest Expense Non Operating | $529,603 | $484,658 | $609,129 | $660,419 |
| Operating Expense | $3,074,561 | $2,614,794 | $2,121,343 | $2,759,562 |
| General And Administrative Expense | $2,910,187 | $2,376,923 | $1,944,912 | $2,561,817 |
| Rent Expense Supplemental | - | - | $0 | $3,683 |
| Total Other Finance Cost | - | - | $1,111,580 | $4,702,918 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-3,398,939 | $-3,029,780 | $-3,842,014 | $-8,045,803 |
| Net Interest Income | $-458,207 | $-375,099 | $-1,720,709 | $-5,363,337 |
| Interest Income | $71,396 | $109,559 | $0 | - |
| Normalized Income | $-3,532,768 | $-2,989,893 | $-3,842,052 | $-8,122,899 |
| Net Income From Continuing And Discontinued Operation | $-3,398,939 | $-3,029,780 | $-3,842,014 | $-8,045,803 |
| Total Operating Income As Reported | $-3,074,561 | $-2,614,794 | $-2,121,343 | $-2,759,562 |
| Net Income Common Stockholders | $-3,398,939 | $-3,029,780 | $-3,842,014 | $-8,045,803 |
| Net Income | $-3,398,939 | $-3,029,780 | $-3,842,014 | $-8,045,803 |
| Net Income Including Noncontrolling Interests | $-3,398,939 | $-3,029,780 | $-3,842,014 | $-8,045,803 |
| Net Income Continuous Operations | $-3,398,939 | $-3,029,780 | $-3,842,014 | $-8,045,803 |
| Pretax Income | $-3,398,939 | $-3,029,780 | $-3,842,014 | $-8,045,803 |
| Special Income Charges | $0 | $-95,872 | $0 | $90,100 |
| Interest Income Non Operating | $71,396 | $109,559 | $0 | - |
| Operating Income | $-3,074,561 | $-2,614,794 | $-2,121,343 | $-2,759,562 |
| Per Share | ||||
| Diluted EPS | $0.00 | $0.00 | $-0.00 | $-0.01 |
| Basic EPS | $0.00 | $0.00 | $-0.00 | $-0.01 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,977,006 | $-2,477,615 | $-3,204,820 | $-7,436,343 |
| Total Unusual Items | $133,829 | $-39,887 | $38 | $77,096 |
| Total Unusual Items Excluding Goodwill | $133,829 | $-39,887 | $38 | $77,096 |
| Reconciled Depreciation | $26,159 | $27,620 | $28,103 | $26,137 |
| EBITDA (Bullshit earnings) | $-2,843,177 | $-2,517,502 | $-3,204,782 | $-7,359,247 |
| EBIT | $-2,869,336 | $-2,545,122 | $-3,232,885 | $-7,385,384 |
| Diluted Average Shares | $1,038,374,219 | $1,033,122,597 | $974,307,366 | $877,612,187 |
| Basic Average Shares | $1,038,374,219 | $1,033,122,597 | $974,307,366 | $877,612,187 |
| Diluted NI Availto Com Stockholders | $-3,398,939 | $-3,029,780 | $-3,842,014 | $-8,045,803 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Impairment Of Capital Assets | $0 | $95,872 | - | - |
| Gain On Sale Of Security | $133,829 | $55,985 | $38 | $-13,004 |
| Research And Development | $164,374 | $237,871 | $176,431 | $197,745 |
| Selling General And Administration | $2,910,187 | $2,376,923 | $1,944,912 | $2,561,817 |
| Other Gand A | $2,037,898 | $1,579,517 | $1,165,170 | $1,823,707 |
| Salaries And Wages | $872,289 | $797,406 | $779,742 | $734,427 |
| Write Off | - | $95,872 | $0 | - |
| Rent And Landing Fees | - | - | $0 | $3,683 |
| Other Special Charges | - | - | - | $-90,100 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-8,149,621 | $-5,707,156 | $-3,521,860 | $-5,295,875 |
| Total Assets | $1,505,333 | $3,232,822 | $4,570,920 | $3,021,912 |
| Total Non Current Assets | $765,048 | $659,202 | $587,479 | $655,797 |
| Non Current Prepaid Assets | $7,174 | $3,518 | $3,518 | $3,518 |
| Current Assets | $740,285 | $2,573,620 | $3,983,441 | $2,366,115 |
| Prepaid Assets | $60,137 | $14,902 | $114,145 | $11,055 |
| Inventory | $6,884 | $6,884 | $6,580 | - |
| Cash Cash Equivalents And Short Term Investments | $673,264 | $2,551,834 | $3,862,716 | $2,355,060 |
| Cash And Cash Equivalents | $673,264 | $2,551,834 | $3,862,716 | $2,355,060 |
| Cash Financial | $673,264 | $2,551,834 | $3,862,716 | $2,355,060 |
| Debt | ||||
| Net Debt | $943,736 | - | - | - |
| Total Debt | $1,704,474 | $1,748,401 | $1,772,141 | $2,420,141 |
| Long Term Debt And Capital Lease Obligation | $40,526 | $54,368 | $20,697 | $155,141 |
| Current Debt And Capital Lease Obligation | $1,663,948 | $1,694,033 | $1,751,444 | $2,265,000 |
| Current Debt | $1,617,000 | $1,652,244 | $1,712,244 | $2,220,423 |
| Other Current Borrowings | - | $35,244 | $95,244 | $563,423 |
| Long Term Debt | - | - | - | $95,244 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $9,654,954 | $8,939,978 | $8,092,780 | $8,317,787 |
| Total Non Current Liabilities Net Minority Interest | $40,526 | $54,368 | $20,697 | $155,141 |
| Current Liabilities | $9,614,428 | $8,885,610 | $8,072,083 | $8,162,646 |
| Current Notes Payable | $1,617,000 | $1,617,000 | $1,617,000 | $1,657,000 |
| Payables And Accrued Expenses | $7,950,480 | $7,191,577 | $6,320,639 | $5,897,646 |
| Interest Payable | $3,128,768 | $2,680,236 | $2,276,454 | $1,901,952 |
| Payables | $863,448 | $994,930 | $961,822 | $1,000,242 |
| Accounts Payable | $502,002 | $541,637 | $540,339 | $587,794 |
| Equity | ||||
| Common Stock Equity | $-13,387,421 | $-10,924,956 | $-8,739,660 | $-10,513,675 |
| Preferred Stock Equity | $5,237,800 | $5,217,800 | $5,217,800 | $5,217,800 |
| Total Equity Gross Minority Interest | $-8,149,621 | $-5,707,156 | $-3,521,860 | $-5,295,875 |
| Stockholders Equity | $-8,149,621 | $-5,707,156 | $-3,521,860 | $-5,295,875 |
| Other Equity Interest | $22,000 | $22,000 | $22,000 | $22,000 |
| Retained Earnings | $-53,085,719 | $-49,686,780 | $-46,657,000 | $-42,814,986 |
| Other | ||||
| Ordinary Shares Number | $1,038,374,219 | $1,038,374,219 | $1,030,940,008 | $927,378,166 |
| Share Issued | $1,038,374,219 | $1,038,374,219 | $1,030,940,008 | $927,378,166 |
| Tangible Book Value | $-13,387,421 | $-10,924,956 | $-8,739,660 | $-10,513,675 |
| Invested Capital | $-11,770,421 | $-9,272,712 | $-7,027,416 | $-8,198,008 |
| Working Capital | $-8,874,143 | $-6,311,990 | $-4,088,642 | $-5,796,531 |
| Capital Lease Obligations | $87,474 | $96,157 | $59,897 | $104,474 |
| Total Capitalization | $-8,149,621 | $-5,707,156 | $-3,521,860 | $-5,200,631 |
| Additional Paid In Capital | $12,290,687 | $11,354,213 | $10,834,729 | $9,894,179 |
| Capital Stock | $32,623,411 | $32,603,411 | $32,278,411 | $27,602,932 |
| Common Stock | $27,385,611 | $27,385,611 | $27,060,611 | $22,385,132 |
| Preferred Stock | $5,237,800 | $5,217,800 | $5,217,800 | $5,217,800 |
| Long Term Capital Lease Obligation | $40,526 | $54,368 | $20,697 | $59,897 |
| Current Capital Lease Obligation | $46,948 | $41,789 | $39,200 | $44,577 |
| Current Accrued Expenses | $7,087,032 | $6,196,647 | $5,358,817 | $4,897,404 |
| Dueto Related Parties Current | $361,446 | $453,293 | $421,483 | $412,448 |
| Investments And Advances | $627,065 | $493,236 | $437,251 | $437,212 |
| Other Investments | $627,065 | $493,236 | $437,251 | $437,212 |
| Net PPE | $130,809 | $162,448 | $146,710 | $215,067 |
| Accumulated Depreciation | $-221,633 | $-195,474 | $-167,854 | $-139,751 |
| Gross PPE | $352,442 | $357,922 | $314,564 | $354,818 |
| Leases | $82,739 | $82,739 | $82,739 | $82,739 |
| Other Properties | $220,638 | $226,118 | $182,760 | $223,014 |
| Machinery Furniture Equipment | $49,065 | $49,065 | $49,065 | $49,065 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,843,326 | $-1,250,882 | $-1,892,208 | $-1,897,963 |
| Operating Activities | ||||
| Operating Cash Flow | $-1,839,086 | $-1,244,483 | $-1,887,187 | $-1,800,809 |
| Cash Flow From Continuing Operating Activities | $-1,839,087 | $-1,244,483 | $-1,887,187 | $-1,800,809 |
| Operating Gains Losses | $855,402 | $538,633 | $234,698 | $559,499 |
| Investing Activities | ||||
| Capital Expenditure | $-4,240 | $-6,399 | $-5,021 | $-97,154 |
| Investing Cash Flow | $-4,240 | $-6,399 | $-5,021 | $-547,370 |
| Cash Flow From Continuing Investing Activities | $-4,240 | $-6,399 | $-5,021 | $-547,370 |
| Financing Activities | ||||
| Financing Cash Flow | $-35,244 | $-60,000 | $3,399,864 | $3,886,332 |
| Cash Flow From Continuing Financing Activities | $-35,244 | $-60,000 | $3,399,864 | $3,886,332 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Net Common Stock Issuance | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-35,244 | $-60,000 | $-100,000 | $-50,000 |
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $673,264 | $2,551,834 | $3,862,716 | $2,355,060 |
| Beginning Cash Position | $2,551,834 | $3,862,716 | $2,355,060 | $816,907 |
| Changes In Cash | $-1,878,570 | $-1,310,882 | $1,507,656 | $1,538,153 |
| Net Issuance Payments Of Debt | $-35,244 | $-60,000 | $2,660,000 | $3,620,000 |
| Net Short Term Debt Issuance | $-35,244 | $-60,000 | $2,660,000 | $3,620,000 |
| Short Term Debt Payments | $-35,244 | $-60,000 | $-100,000 | $-50,000 |
| Net Investment Purchase And Sale | $0 | $0 | $0 | $-450,216 |
| Sale Of Investment | $0 | $2,587,811 | $0 | - |
| Purchase Of Investment | $0 | $-2,587,811 | $0 | $-450,216 |
| Net PPE Purchase And Sale | $-4,240 | $-6,399 | $-5,021 | $-97,154 |
| Purchase Of PPE | $-4,240 | $-6,399 | $-5,021 | $-97,154 |
| Change In Working Capital | $731,048 | $873,306 | $499,635 | $618,485 |
| Change In Other Current Liabilities | $-48,172 | $-48,763 | $-44,577 | $-104,417 |
| Change In Other Current Assets | $49,209 | $48,064 | $45,275 | $90,072 |
| Change In Payables And Accrued Expense | $778,903 | $870,938 | $608,607 | $641,297 |
| Change In Accrued Expense | $818,538 | $869,640 | $470,448 | $441,574 |
| Change In Payable | $-39,635 | $1,298 | $138,159 | $199,723 |
| Change In Account Payable | $-39,635 | $1,298 | $138,159 | $199,723 |
| Change In Prepaid Assets | $-48,892 | $3,371 | $-103,090 | $-8,467 |
| Change In Inventory | $0 | $-304 | $-6,580 | $0 |
| Other Non Cash Items | $-52,756 | $24,866 | $1,192,391 | $4,798,773 |
| Stock Based Compensation | $0 | $225,000 | $0 | $242,100 |
| Asset Impairment Charge | $0 | $95,872 | $0 | - |
| Depreciation Amortization Depletion | $26,159 | $27,620 | $28,103 | $26,137 |
| Depreciation And Amortization | $26,159 | $27,620 | $28,103 | $26,137 |
| Depreciation | $26,159 | $27,620 | $28,103 | $26,137 |
| Gain Loss On Investment Securities | $855,402 | $538,633 | $234,698 | $600,278 |
| Net Income From Continuing Operations | $-3,398,939 | $-3,029,780 | $-3,842,014 | $-8,045,803 |
| Issuance Of Debt | - | $0 | $2,760,000 | $3,670,000 |
| Proceeds From Stock Option Exercised | - | $0 | $739,864 | $266,332 |
| Short Term Debt Issuance | - | $0 | $2,760,000 | $3,670,000 |
| Net Long Term Debt Issuance | - | - | $-60,000 | $3,670,000 |
| Long Term Debt Payments | - | - | $-60,000 | $-50,000 |
| Gain Loss On Sale Of PPE | - | - | $0 | $49,321 |
| Long Term Debt Issuance | - | - | - | $3,670,000 |
| Depletion | - | - | - | $13,004 |
Fetched: 2026-02-02